SYNTA PHARMACEUTICALS CORP 4
4 · SYNTA PHARMACEUTICALS CORP · Filed Dec 20, 2013
Insider Transaction Report
Form 4
Bernitz Steven B
SVP, Corporate Development
Transactions
- Award
Common Stock
2013-12-18$0.00/sh+25,000$3→ 25,000 total - Award
Employee Stock Option (Right to Buy)
2013-12-18+150,000→ 150,000 totalExercise: $4.34Exp: 2023-12-18→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 50% of the shares on each of December 18, 2015 and December 18, 2016, provided the Reporting Person remains employed by the Issuer on such date.
- [F2]The option vests as to 25% of the shares on Decmeber 18, 2014 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.